Skip to content

Generations for Heart Health

3-2-GenHealth: A Familism-Informed Pilot to Engage Mothers and Grandmothers in Cardiovascular Research and Prevention

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07901439
Enrollment
60
Registered
2026-10-28
Start date
2026-11-01
Completion date
2027-12-31
Last updated
2026-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Health

Keywords

mHealth, Cardiovascular Health, Wearable Device, Women's health

Brief summary

Heart disease is the leading cause of death for women in the United States, and many women find it hard to prioritize their own health while caring for family. This randomized control trial pilot aims to test whether linking heart-healthy habits to a woman's role as a mother or grandmother can increase physical activity and improve other heart-healthy behaviors. The study will enroll mothers and grandmothers of young children, who may join as a mother-grandmother pair or on their own. All participants will complete a baseline questionnaire (self-reported cardiovascular health including physical activity), followed by 4 weeks of wearing an activity tracker (such as a Fitbit) and a post-study period questionnaire (repeating baseline measures). After the first baseline week, participants will be randomly assigned, with pairs assigned together, to an intervention or comparison group. The intervention group will complete a short online writing activity about their caregiving role and personal values, then receive 2 weeks of daily text messages linking their health and physical activity to the health of their children and family, followed by a fourth observational week where no messaging is delivered. The comparison group will also wear the tracker for 4 weeks, but will receive 2 weeks of general daily messages (a greeting + device use reminder). The main question is whether the intervention group is more engaged in the study activities during the text message period.

Interventions

Will be used to provide objectively measured data on daily steps and other physical activity metrics over the study period.

BEHAVIORALText Messages

Self-affirmation-based text messages.

Sponsors

NYU Langone Health
Lead SponsorOTHER
National Center for Advancing Translational Sciences (NCATS)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Mother or grandmother (\>= 18 years) of a child aged 0-13 years * Able to read and understand English or Spanish * Engages in less than 150 minutes (total) of moderate-to-vigorous physical activity (MVPA) per week (self-reported) at baseline * Owns a mobile phone capable of receiving text messages * Able and willing to use a wearable activity tracker

Exclusion criteria

• Known medical condition(s) that significantly limit(s) safe participation in light-moderate physical activity (e.g., symptomatic cardiovascular disease, history of heart attack, recent major surgery)

Design outcomes

Primary

MeasureTime frameDescription
Fitbit Average Daily Wear TimeWeek 2, Week 3Average number of minutes worn per day

Secondary

MeasureTime frameDescription
Fitbit Proportion of Wear TimeWeek 2, Week 3Proportion of days worn of intended study period.
Daily Moderate-to-Vigorous Physical Activity (MVPA)Week 2, Week 3Average daily MVPA by wearable device and by self-reported IPAQ-SF.
Engagement in Intervention ComponentsUp to Week 4Composite measure of the proportion of participants completing self-affirmation task; self-reported proportion of text-messages read; text-message satisfaction.
Fitbit Average Daily Wear Time during 1-Week Post-InterventionWeek 4Average number of minutes worn per day.
AttritionUp to Week 3Proportion of Participants who opt-out of text-messages.

Countries

United States

Contacts

CONTACTRobin Ortiz, MD, MS
Robin.Ortiz@nyulangone.org646-965-3864
CONTACTElaine De Leon
Elaine.DeLeon@nyulangone.org646-501-3752
PRINCIPAL_INVESTIGATORRobin Ortiz, MD, MS

NYU Langone Health

PRINCIPAL_INVESTIGATORElaine De Leon, MD

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Oct 29, 2026